在对耐碳青霉烯类肠杆菌科细菌进行头孢地尔药敏试验时，将ComASP®和UMIC®方法与参考方法进行比较。 - Suppr

Comparison of ComASP® and UMIC® methods with the reference method for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales.

作者信息

Emeraud Cécile, Gonzalez Camille, Dortet Laurent

机构信息

Department of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.

UMR-1184, INSERM, University Paris-Saclay, CEA, Faculty of Medicine, Le Kremlin-Bicêtre, France.

出版信息

J Antimicrob Chemother. 2023 Jul 5;78(7):1800-1801. doi: 10.1093/jac/dkad134.

DOI:10.1093/jac/dkad134

PMID:37141286

Abstract

摘要

相似文献

Comparison of ComASP® and UMIC® methods with the reference method for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales.

J Antimicrob Chemother. 2023 Jul 5;78(7):1800-1801. doi: 10.1093/jac/dkad134.

Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus.

Ann Clin Microbiol Antimicrob. 2024 Aug 22;23(1):78. doi: 10.1186/s12941-024-00731-1.

Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria.

J Antimicrob Chemother. 2023 Jul 5;78(7):1672-1676. doi: 10.1093/jac/dkad149.

Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales.

Clin Microbiol Infect. 2022 Aug;28(8):1156.e1-1156.e5. doi: 10.1016/j.cmi.2022.04.013. Epub 2022 May 6.

Disc Diffusion and ComASP Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine.

Antibiotics (Basel). 2023 Mar 17;12(3):604. doi: 10.3390/antibiotics12030604.

Activity of Cefiderocol Against , , and Endemic to Medical Centers in New York City.

Microb Drug Resist. 2020 Jul;26(7):722-726. doi: 10.1089/mdr.2019.0298. Epub 2020 Feb 7.

Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in Enterobacterales.

J Antimicrob Chemother. 2022 Nov 28;77(12):3456-3461. doi: 10.1093/jac/dkac340.

In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection.

Clin Microbiol Infect. 2022 Mar;28(3):447.e1-447.e6. doi: 10.1016/j.cmi.2021.07.018. Epub 2021 Jul 21.

Activities of Cefiderocol with Simulated Human Plasma Concentrations against Carbapenem-Resistant Gram-Negative Bacilli in an Chemostat Model.

Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.01128-20.

New Perspectives on Antimicrobial Agents: Cefiderocol.

Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0217120. doi: 10.1128/AAC.02171-20.

引用本文的文献

Evaluating Antimicrobial Susceptibility Testing Methods for Cefiderocol: A Review and Expert Opinion on Current Practices and Future Directions.

Antibiotics (Basel). 2025 Jul 28;14(8):760. doi: 10.3390/antibiotics14080760.

The impact of commercially available media on cefiderocol susceptibility testing by broth microdilution method.

J Clin Microbiol. 2025 Sep 10;63(9):e0047125. doi: 10.1128/jcm.00471-25. Epub 2025 Aug 20.

Real-Life Cefiderocol Use in Bone and Joint Infection: A French National Cohort.

Antibiotics (Basel). 2025 Apr 8;14(4):388. doi: 10.3390/antibiotics14040388.

TROJAN-MDR: in vitro activity of cefiderocol and comparators against multidrug-resistant Enterobacterales and Pseudomonas aeruginosa strains in Southern France, evaluation of available testing methods performances.

Ann Clin Microbiol Antimicrob. 2025 Mar 19;24(1):20. doi: 10.1186/s12941-025-00785-9.

A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution.

J Clin Microbiol. 2025 Feb 19;63(2):e0092624. doi: 10.1128/jcm.00926-24. Epub 2024 Dec 31.

Real-world performance of susceptibility testing for cefiderocol: insights from a prospective multicentre study on Gram-negative bacteria.

JAC Antimicrob Resist. 2024 Oct 24;6(5):dlae169. doi: 10.1093/jacamr/dlae169. eCollection 2024 Oct.

Issues with Cefiderocol Testing: Comparing Commercial Methods to Broth Microdilution in Iron-Depleted Medium-Analyses of the Performances, ATU, and Trailing Effect According to EUCAST Initial and Revised Interpretation Criteria.

Diagnostics (Basel). 2024 Oct 18;14(20):2318. doi: 10.3390/diagnostics14202318.

Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus.

Ann Clin Microbiol Antimicrob. 2024 Aug 22;23(1):78. doi: 10.1186/s12941-024-00731-1.

Performance evaluation of Bruker UMIC microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species.

Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):559-566. doi: 10.1007/s10096-024-04745-7. Epub 2024 Jan 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Comparison of ComASP® and UMIC® methods with the reference method for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献